CJ Bioscience, Inc. (KOSDAQ:311690)

CJ Bioscience Revenue

CJ Bioscience had revenue of 898.15M KRW in the quarter ending June 30, 2026, with 14.59% growth. This brings the company's total for the last twelve months to 3.68B, up 8.72% year-over-year. In the year 2025, CJ Bioscience had annual revenue of 3.69B with 6.52% growth. That makes CJ Bioscience the 41,659th largest company in the world by revenue and 2,543rd in South Korea.

• Revenue (ttm): 3.68B
• Revenue Growth: +8.72%
• P/S Ratio: 12.81
• Revenue / Employee: 45.40M
• Employees: 81
• Market Cap: 48.15B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 3.25B 87.9%
• Overseas 446.61M 12.1%

Fiscal year ended Dec 31, 2025 See the full CJ Bioscience breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.69B	225.99M	6.52%
Dec 31, 2024	3.47B	-2.11B	-37.82%
Dec 31, 2023	5.58B	1.50B	36.82%
Dec 31, 2022	4.07B	-288.37M	-6.61%
Dec 31, 2021	4.36B	-948.52M	-17.86%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error